HCP Data Providers Compared: IQVIA vs EmailAddress.ai

Your pharma brand manager just got back from a vendor demo. IQVIA quoted a six-figure annual contract. Definitive Healthcare wants three years upfront. Veeva OpenData requires you to already run Veeva CRM. And somewhere in that conversation, nobody actually answered the question you came in with: how do I reach the right physicians with a verified email address?

That disconnect is at the heart of how HCP data providers are evaluated in 2026. Most of the well-known platforms in this space were built for market intelligence, claims analytics, and CRM reference data. They’re powerful for what they do. But if your primary use case is outreach-ready HCP contact data with verified emails, specialty filters, and no three-year lock-in, you’re often buying the wrong product at the wrong price.

This HCP data providers comparison covers the four most commonly evaluated platforms by pharma marketing, medical device, and healthcare technology teams. For each one: what it actually does, who it’s built for, where it falls short, and what it costs you in practice.

Quick Answer

The best HCP data provider depends on your use case. IQVIA OneKey and Veeva OpenData are enterprise reference databases built for CRM master data management and compliance, not direct outreach. Definitive Healthcare is an analytics platform primarily oriented toward market intelligence. EmailAddress.ai provides NPI-verified, outreach-ready HCP contact data with email verification and specialty filtering – with no multi-year contract requirement – making it the most accessible option for pharma marketing, medical device, and healthcare technology teams that need to reach physicians directly.

In This Comparison

The Category Confusion That Wastes Budget
IQVIA OneKey: The Enterprise Incumbent
Definitive Healthcare: Analytics First, Contacts Second
Veeva OpenData: Excellent Inside the Ecosystem, Painful Outside
EmailAddress.ai: HCP Contact Data Built for Outreach Teams
Side-by-Side Comparison Table
Which HCP Data Provider Is Right for Your Use Case
Frequently Asked Questions

The Category Confusion That Wastes HCP Data Budget

HCP data is not a single product category. It’s four or five different things bundled under the same label. Pharma commercial teams, medical device companies, and healthcare technology firms are often comparing vendors that are solving fundamentally different problems – and paying enterprise prices for capabilities they don’t need.

Before any vendor evaluation, you need to know which category you’re actually buying. The major categories are:

HCP reference data: Master data management – NPI-linked records, compliance flags, affiliations, used to power CRM systems and maintain a single source of truth across the organization. IQVIA OneKey and Veeva OpenData are the dominant players.
Healthcare market intelligence: Claims data, procedure volumes, Rx patterns, org hierarchy, prescribing deciles. Used for market sizing, territory planning, and identifying high-value targets. Definitive Healthcare and H1 Insights lead here.
HCP contact data for outreach: Verified direct email addresses, phone numbers, and specialty filters attached to NPI-verified physician records, ready for campaign deployment. This is what EmailAddress.ai and SparkDBI provide.
KOL and medical affairs intelligence: Key opinion leader mapping, publication records, clinical trial participation, peer influence networks. H1 Insights and AcuityMD specialize here.

Most buyer confusion happens at the intersection of categories one and three. Teams need physician email addresses for a product launch campaign. They evaluate the biggest names in the space – IQVIA, Definitive Healthcare, Veeva – get quoted five-figure minimums for platforms built around reference data and analytics, and either overspend on capabilities they don’t use or walk away without solving the original problem.

Market Context

According to a 2025 State of HCP Engagement report, 82% of pharma executives believe their digital outreach is effective – but only 28% of HCPs agree. The gap is not primarily a messaging problem. It’s a data quality and targeting problem. Reaching the right physician at the right address is step zero.

IQVIA OneKey: The Enterprise Incumbent

IQVIA OneKey is the largest HCP reference database in the world. That is not marketing copy – it is an accurate statement about scale. The platform covers more than 25 million HCPs and 6 million healthcare organizations across 118 countries, including approximately 1.2 million US physicians spanning 248 specialties. Each record contains over 250 attributes, and the database receives more than 1.5 million updates globally each month. IQVIA is ISO 9001 certified and is audited by the Alliance for Audited Media.

When IQVIA says 99%+ data accuracy, they are referring to a 2025 random demographic audit of core record fields – NPI, specialty, practice address, institutional affiliation. That is the data that their enterprise clients use to power Veeva CRM, IQVIA OCE, and other field force management systems. It is rigorous, and it is built for that specific purpose.

What IQVIA OneKey does well

The most comprehensive global HCP reference database available – no other vendor comes close on global coverage
Native integration with Rx and claims data (IQVIA Xponent, LRx) – covers approximately 90-93% of US retail pharmacy claims for prescriber-level analysis
Designed for pharmaceutical compliance and Sunshine Act tracking across large field forces
300 data operators conducting primary research, over 1,000 external industry sources
ISO 9001 certified – the most rigorous quality standard in the space

Where IQVIA OneKey falls short

Pricing and contract structure: IQVIA is an enterprise vendor with enterprise pricing. Multi-year contracts are standard. Access to the full OneKey dataset starts at six figures annually for most organizations. This is not designed for teams that need to run a 10,000-contact HCP email campaign and move on.
Email accuracy for direct outreach: OneKey’s 99%+ accuracy figure applies to demographic and identity data. Direct email addresses – the working inbox a physician checks – are a different matter. OneKey records frequently carry institutional or role-based email formats rather than verified direct-contact emails. Healthcare institutions are disproportionately catch-all configured, meaning an address that SMTP-pings as valid may not deliver to a live inbox.
Ecosystem dependency: OneKey is most useful inside the IQVIA ecosystem or connected to Veeva CRM and other compatible systems. Teams running Salesforce, HubSpot, or custom CRM environments will encounter data export and integration friction.
Not built for mid-market: A specialty pharma team of 12 reps targeting one therapeutic area in three states does not need IQVIA OneKey. The product was designed for global pharmaceutical enterprises managing thousands of field interactions monthly.

IQVIA 2026 snapshot: Full-year 2025 revenue guidance raised to $16.0-16.4 billion. 25M+ HCPs, 118 countries, 1,000+ data attributes per record, 1.5M monthly updates, 300 primary research operators. Built for enterprise pharma. Not built for direct outreach email campaigns.

Definitive Healthcare: Analytics First, Contacts Second

Definitive Healthcare is a publicly traded analytics firm (Nasdaq: DH) with approximately $237-240 million in projected 2025 revenue. The platform covers more than 3 million US HCP profiles and 310,000 healthcare organizations, linked to 28 billion Rx claims and 12.5 billion medical claims. Those numbers represent serious analytics capability.

The product is primarily oriented toward healthcare commercial intelligence – understanding hospital org structures, identifying which physicians are driving procedure volume in a given market, mapping IDN relationships, and running go-to-market strategy analysis. Medical device companies and hospital-focused vendors get strong value from the analytics depth. This is not the same as getting a verified email address for a cardiologist.

What Definitive Healthcare does well

Claims-linked intelligence: 28B Rx claims and 12.5B medical claims tied to identifiable providers – one of the deepest procedure and prescribing intelligence datasets available
Hospital and IDN mapping: org hierarchy data, C-suite contacts, facility performance metrics – strong for hospital-focused device and services sales
Real-time data model with updates pushed continuously rather than on batch refresh cycles
US-focused but with strong coverage depth across physician, NP, PA, and allied health populations

Where Definitive Healthcare falls short

Contract terms are a recurring complaint: G2 reviews consistently flag mandatory 3-year contracts, automatic 3-year renewals with no adequate warning, and 5-8% annual price escalation clauses. Multiple verified reviews describe teams locked into contracts after cancellation windows were missed by days. One representative review: “Even after verbally and electronically cancelling, they will send you to collections and threaten lawsuits long after your account has been terminated.”
Contact information is not the primary product: Definitive Healthcare collects business emails, phone numbers, and supplemental contact data – but these are secondary to the analytics. Email coverage rates vary significantly by specialty and practice type. Teams that need high email coverage for outreach campaigns often find gaps.
Pricing and negotiation complexity: The Salesforce integration alone carries a separate $22,000 license fee (waivable with negotiation). Redline threshold estimates from procurement data put meaningful negotiations starting at $100K+. End-of-quarter pressure tactics are widely documented in user reviews.
US-only for contact data: Despite broad HCO data, Definitive’s HCP contact profiles are primarily US and Canada. Teams running global pharma outreach programs will hit coverage walls quickly.

Need NPI-verified HCP contact data without a 3-year contract?

EmailAddress.ai provides verified physician email data by specialty, with no multi-year lock-in. See your target specialty’s coverage before you commit.See HCP Data Licensing Options

Veeva OpenData: Excellent Inside the Ecosystem, Painful Outside It

Veeva OpenData is genuinely strong HCP reference data – when you’re using Veeva CRM. That qualification matters more than any other single fact about this product.

The database covers approximately 20 million global HCP and HCO profiles across 100+ countries. Records contain verified addresses, emails, specialty data, DEA numbers where applicable, compliance flags, and institutional affiliations. Veeva’s stewardship team resolves 99% of data change requests within one business day. For a large pharma company running Vault CRM with a field force of hundreds of reps, OpenData is the logical choice – it feeds the CRM natively, updates automatically, and handles compliance tracking in one integrated workflow.

What Veeva OpenData does well

Native integration with Veeva Vault CRM and the broader Veeva Commercial Cloud – data populates directly without mapping or transformation
Compliance data built in: sample eligibility flags, state license status, DEA registration, Sunshine Act tracking fields
Stewardship services with 99% of data change requests resolved within one business day – among the fastest turnaround in the space
2025 introduced OpenData Live, extending real-time HCP access across compliance, KAM, and market access teams beyond just field reps
Priced per-record per-country with a defined cap – more predictable than usage-based models for large deployments

Where Veeva OpenData falls short

Ecosystem lock-in is real: If you don’t run Veeva CRM, OpenData provides limited standalone value. Verified user feedback: “The HCP data quality is excellent within the Veeva ecosystem. But when we tried to use it outside Veeva CRM for a marketing campaign, the proprietary codes and export limitations made it a nightmare.” Teams on Salesforce, HubSpot, or any non-Veeva stack will face integration friction.
Total cost of ownership: OpenData is priced by HCP records per country, but the full commercial package – CRM + OpenData + implementation consulting + user training – routinely comes in at $80K-$150K+ annually for mid-market teams. One evaluated proposal for a 12-person medical device sales team returned a bundled quote of $150K+.
Proprietary specialty codes: Veeva uses its own specialty classification rather than industry-standard NUCC taxonomy. Exporting data for use in other systems requires re-mapping specialty codes, which adds a manual step to every campaign workflow.
Implementation timeline: Getting OpenData into production requires data mapping, CRM configuration, user training, and integration testing measured in months. Teams with a campaign launching in four weeks cannot run on Veeva’s onboarding timeline.
Email deliverability not the focus: OpenData provides verified emails for US HCPs, but the platform is not built around deliverability verification or catch-all resolution. Hospital and health system domains – where catch-all configurations are common – can carry email addresses that SMTP-verify as valid but do not deliver to live inboxes.

EmailAddress.ai: HCP Contact Data Built for Outreach Teams

EmailAddress.ai is an AI-powered email verification and HCP contact data platform serving pharma marketing teams, medical device companies, and healthcare technology vendors that need to reach physicians directly. The HCP data licensing offering provides NPI-verified physician contact records – direct email addresses, phone numbers, specialty filters – with an email verification layer built in at the point of delivery.

This is a different product category from IQVIA, Definitive Healthcare, and Veeva. EmailAddress.ai does not provide claims data, procedure volume intelligence, or Sunshine Act compliance tracking. What it provides is the one thing the enterprise platforms often get wrong: a physician email address you can confidently send to.

The HCP email deliverability problem the incumbents don’t solve

Medical institutions, hospital systems, academic medical centers, and large physician group practices are disproportionately catch-all email configurations. This means their mail servers accept any inbound message regardless of whether the specific mailbox is active. A standard SMTP verification ping returns a positive response, the record gets marked “valid,” and the email you send to that physician lands nowhere – or bounces three days after your campaign launched.

EmailAddress.ai’s catch-all verification engine resolves this at the individual address level using a multi-signal AI classification model – not a blanket domain-level verdict. For HCP email lists, where institutional domains are common and catch-all rates can exceed 30% of the database, this distinction is what separates a campaign that performs from one that generates bounces and domain reputation damage. The mechanics of this are covered in detail in the catch-all verification guide for HCP campaigns.

What EmailAddress.ai provides

NPI-verified physician contact records with direct email addresses by specialty, geography, and practice setting
AI-powered email verification built into the HCP data delivery – addresses are verified, not just sourced
Catch-all domain resolution for hospital and health system email infrastructure – the capability that most platforms skip
50+ specialty filters covering physicians, NPs, PAs, and allied health professionals
No multi-year contract requirement – access structured around your actual campaign needs
CRM-agnostic flat-file and API delivery – works with Salesforce, HubSpot, Veeva, or any custom stack
Published accuracy methodology detailing exactly how records are verified
HIPAA-aligned sourcing and compliance documentation

What EmailAddress.ai does not provide

Claims data, Rx prescribing volumes, or procedure intelligence – teams that need prescriber decile analysis should look at IQVIA or Definitive Healthcare for that layer
CRM master data management or Sunshine Act compliance tracking – that’s the IQVIA OneKey and Veeva OpenData use case
KOL mapping, publication records, or clinical trial participation data – H1 Insights is purpose-built for that

The honest positioning: if you need to understand market dynamics, map IDN hierarchies, or power a 500-rep field force CRM, EmailAddress.ai is not the right tool. If you need to launch an HCP email campaign to oncologists in five states with verified direct-contact emails and bounce rates under 2%, it’s the right tool – and the enterprise alternatives are the wrong ones.

Side-by-Side HCP Data Provider Comparison

The table below compares each platform across the dimensions that matter most to pharma marketing, medical device, and healthcare technology teams evaluating HCP data for outreach programs.

Evaluation Criteria	IQVIA OneKey	Definitive Healthcare	Veeva OpenData	EmailAddress.ai
Primary Use Case	CRM reference data, enterprise field force	Healthcare market intelligence, analytics	Veeva CRM master data, compliance	Verified HCP outreach contact data
HCP Record Count	25M+ (118 countries)	3M+ (US/Canada)	20M+ (100+ countries)	16M+ NPI-verified US + global HCP (100+ countries)
Verified Email Addresses	Institutional (not deliverability-verified)	Variable coverage, not primary product	Included for US, not deliverability-verified	AI-verified, catch-all resolved
Catch-All Domain Handling	Not addressed	Not addressed	Not addressed	AI-layered resolution per address
Contract Structure	Multi-year enterprise contract	3-year minimum, auto-renew	Annual per-record/country, CRM bundle	No multi-year lock-in
Entry Price Point	6-figure annual minimum	$50K-$200K+ (3-year required)	$80K-$150K+ (CRM bundle)	Transparent, campaign-based pricing
CRM Dependency	Best in IQVIA OCE ecosystem	Salesforce integration ($22K add-on)	Requires Veeva CRM for full value	CRM-agnostic, flat-file or API
Claims / Rx Data	Yes (Xponent, LRx)	Yes (Atlas 28B+ claims)	Limited – CRM reference only	Contact data focus – pair with claims source
Best Fit For	Top 20 pharma, large field forces	Hospital/device market sizing	Enterprise pharma on Veeva CRM	Pharma marketing, device, health tech outreach

Which HCP Data Provider Is Right for Your Use Case

No single platform is right for every team. The decision depends almost entirely on what you need the data to do once you have it. Here’s how to map your use case to the right solution.

Choose IQVIA OneKey if:

You are a top-20 global pharmaceutical company with hundreds of field reps who need a master HCP reference database to power a CRM system
You need Rx prescribing data (Xponent) tied directly to your physician universe
Compliance, Sunshine Act tracking, and global regulatory requirements are primary operational concerns
You have a budget north of $100K annually and multi-year commitment is acceptable

Select Definitive Healthcare if:

Your primary need is healthcare market intelligence – hospital buying patterns, IDN hierarchy, procedure volumes, and go-to-market territory strategy
You are a medical device or hospital services company sizing a market before deploying a field force
You have negotiating leverage and legal review to handle aggressive auto-renewal contract terms before signing
You can justify a 3-year contract and have thoroughly tested the data quality for your specific use case before committing

Go with Veeva OpenData if:

You are already running Veeva Vault CRM and need a native HCP reference database to feed it
Your compliance and stewardship requirements demand a platform that integrates at the CRM layer
You are a large pharma organization and the $80K-$150K+ total cost of ownership fits your budget model

Choose EmailAddress.ai HCP Data if:

Your primary objective is executing an HCP email outreach campaign – product launch, formulary update, CME invitation, or awareness program
You need specialty-filtered, NPI-verified physician email lists with deliverability guaranteed by AI catch-all verification
Your CRM is Salesforce, HubSpot, or any non-Veeva system, and you need data in flat-file or API format
You are a specialty pharma team, medical device company, or healthcare tech firm that cannot justify six-figure enterprise platform costs
You want to verify data quality against your own list before any commitment – the HCP data licensing page outlines how to get started

The HCP data market is consolidating around two distinct buyer types: large pharma enterprises that need integrated commercial intelligence platforms, and mid-market teams that need outreach-ready contact data without CRM dependency or multi-year commitment. The enterprise platforms were built for the first buyer. EmailAddress.ai was built for the second.

Key Takeaways: HCP Data Providers 2026

IQVIA OneKey is the world’s largest HCP reference database – right for enterprise pharma CRM and compliance, wrong for direct outreach campaigns
Definitive Healthcare is a healthcare analytics platform with powerful claims intelligence and notoriously aggressive contract terms
Veeva OpenData delivers excellent data quality inside the Veeva CRM ecosystem and is a burden outside it
EmailAddress.ai provides the category these platforms underserve: NPI-verified, deliverability-verified HCP contact data with catch-all resolution for hospital domains
Catch-all configurations affect 20-35% of enterprise HCP email databases – none of the incumbent platforms address this at the individual address level
No multi-year contract requirement and CRM-agnostic delivery are the practical differentiators for mid-market pharma, device, and health tech teams

Frequently Asked Questions

What is HCP data and why do pharma companies use it?

HCP data is structured information about healthcare professionals – physicians, nurse practitioners, physician assistants, pharmacists, and other licensed providers. Pharma companies use HCP data to identify and reach prescribers for product launches, formulary education, clinical trial recruitment, and CME programs. The data typically includes NPI numbers, specialty classifications, practice addresses, contact information, and where available, prescribing or procedure volume data. Quality HCP data is NPI-verified, meaning every record ties back to the CMS National Provider Identifier registry, which provides independent verification of the physician’s identity, specialty, and license status.

How does IQVIA OneKey compare to Definitive Healthcare?

IQVIA OneKey and Definitive Healthcare serve different primary use cases despite both being classified as HCP data platforms. IQVIA OneKey is a reference database built for master data management – it feeds CRM systems and compliance workflows at enterprise pharma companies, with 25M+ global HCPs and integrated Rx prescribing data. Definitive Healthcare is primarily a healthcare market intelligence platform, with 28 billion Rx claims and 12.5 billion medical claims linked to provider profiles, best suited for market sizing, territory strategy, and hospital-focused commercial intelligence. Neither was built with email deliverability as a core requirement, which is the gap that purpose-built HCP contact data providers address.

Is Definitive Healthcare worth the 3-year contract?

Definitive Healthcare can deliver strong value for healthcare market intelligence – hospital analytics, IDN mapping, and claims-based procedure intelligence are genuinely useful capabilities for device and hospital services companies. The contract structure is the primary risk. Multiple verified G2 and procurement forum reviews document automatic 3-year renewals, 5-8% annual escalation clauses, and aggressive collections enforcement on cancellations. If you evaluate Definitive Healthcare, engage legal counsel on the contract terms before signing, explicitly negotiate the auto-renewal window, and confirm the specific data fields you need are populated for your target specialty before committing to a multi-year term.

Can I use Veeva OpenData without Veeva CRM?

Technically yes – Veeva OpenData can be accessed via API outside the CRM context. In practice, the per-record pricing, proprietary specialty taxonomy, and implementation requirements make OpenData outside the Veeva CRM ecosystem a poor fit for most teams. Reported total costs for mid-market teams evaluating OpenData standalone have come in at $80K-$150K+ annually. The value proposition of OpenData – native CRM population, stewardship services, and compliance flags – largely disappears when you’re not running Vault CRM. Teams on Salesforce, HubSpot, or custom stacks should evaluate CRM-agnostic HCP contact data providers instead.

What makes HCP email data different from standard B2B contact data?

HCP email data has several characteristics that make standard B2B verification approaches inadequate. Medical institutions, hospital systems, and large physician group practices commonly run catch-all email configurations, meaning any address at the domain SMTP-validates as positive even if the specific mailbox is inactive. HCP job changes – physicians moving between practices, leaving academic medicine, or retiring – create data decay that outpaces standard B2B rates. Compliance considerations are also more nuanced: institutional email addresses are monitored or filtered differently from personal professional emails. Purpose-built HCP contact data platforms address these characteristics directly, using AI-layered catch-all resolution and NPI-cross-referenced verification to ensure outreach-ready deliverability rather than just SMTP-valid status.

How often should HCP contact data be refreshed?

HCP contact data should be verified before every major campaign deployment, not just at the point of initial list acquisition. Physician job changes, practice relocations, and institutional email infrastructure updates create continuous decay. As per American Medical Association workforce data, physician career transitions – between academic and private practice, between institutions, into retirement – occur throughout the year and are not concentrated in any single season. A verified HCP email list from six months ago can carry meaningful bounce risk by the time it reaches a campaign. The most reliable approach is to re-verify against a current catch-all resolution engine at or near send time rather than relying solely on point-in-time verification.

Ready to Evaluate HCP Contact Data for Your Next Campaign?

See EmailAddress.ai’s HCP data coverage by specialty and geography before you commit. NPI-verified, AI catch-all resolved, no multi-year contract.Explore HCP Data Licensing Talk to a Specialist

Gautam Mane | B2B Data and Email Deliverability Specialist
Gautam has 8+ years of experience in B2B data quality, healthcare data, and outbound email strategy across Asia-Pacific and global markets. He writes about HCP data, email verification, and deliverability for the EmailAddress.ai and SparkDBI content programs.